GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brain+ AS (OCSE:BRAINP) » Definitions » Net Margin %

Brain+ AS (OCSE:BRAINP) Net Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Brain+ AS Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Brain+ AS's Net Income for the six months ended in Dec. 2023 was kr-13.05 Mil. Brain+ AS's Revenue for the six months ended in Dec. 2023 was kr0.00 Mil. Therefore, Brain+ AS's net margin for the quarter that ended in Dec. 2023 was 0.00%.

The historical rank and industry rank for Brain+ AS's Net Margin % or its related term are showing as below:


OCSE:BRAINP's Net Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.82
* Ranked among companies with meaningful Net Margin % only.

Brain+ AS Net Margin % Historical Data

The historical data trend for Brain+ AS's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain+ AS Net Margin % Chart

Brain+ AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
- - - - -

Brain+ AS Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Brain+ AS's Net Margin %

For the Health Information Services subindustry, Brain+ AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brain+ AS's Net Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Brain+ AS's Net Margin % distribution charts can be found below:

* The bar in red indicates where Brain+ AS's Net Margin % falls into.



Brain+ AS Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Brain+ AS's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-19.125/0
= %

Brain+ AS's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-13.051/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brain+ AS  (OCSE:BRAINP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Brain+ AS Net Margin % Related Terms

Thank you for viewing the detailed overview of Brain+ AS's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Brain+ AS (OCSE:BRAINP) Business Description

Traded in Other Exchanges
N/A
Address
Kobmagergade 53, 3rd Floor, Copenhagen, DNK, DK-1150
Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).

Brain+ AS (OCSE:BRAINP) Headlines

No Headlines